Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
UBS
Covington
Cerilliant
Argus Health
Dow
Cipla
Cantor Fitzgerald
Merck

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,599,498

« Back to Dashboard

Which drugs does patent 6,599,498 protect, and when does it expire?

Patent 6,599,498 protects FERAHEME and is included in one NDA.

This patent has eleven patent family members in ten countries.
Summary for Patent: 6,599,498
Title: Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives
Abstract:Compositions, methods of making the compositions, and methods of using the compositions are provided for an enhanced magnetic resonance imaging agent and a hematinic agent, the agents comprising carboxyalkylated reduced polysaccharides coated ultrasmall superparamagnetic iron oxides. Methods of use of the carboxymethyl reduced dextran as a plasma extender are provided.
Inventor(s): Groman; Ernest V. (Brookline, MA), Paul; Kenneth G. (Holliston, MA), Frigo; Timothy B. (Waltham, MA), Bengele; Howard (Canton, MA), Lewis; Jerome M. (Newton, MA)
Assignee: Advanced Magnetics, Inc. (Cambridge, MA)
Application Number:09/521,264
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 6,599,498

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Amag Pharms Inc FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,599,498

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,501,158 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Try a Free Trial
8,591,864 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Try a Free Trial
7,553,479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof ➤ Try a Free Trial
9,555,133 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,599,498

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Portugal 1169062 ➤ Try a Free Trial
Luxembourg 92114 ➤ Try a Free Trial
Japan 2011046752 ➤ Try a Free Trial
Japan 5064612 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Cerilliant
Cantor Fitzgerald
McKesson
Citi
US Army
Fish and Richardson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.